Gut Microbes

Article	Citations
Blautia—a new functional genus with potential probiotic properties?	540
Gut Bacteroides species in health and disease	391
The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health	257
Gut microbes from the phylogenetically diverse genusEubacteriumand their various contributions to gut health	242
Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice	216
Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review	211
Intestinal Cetobacterium and acetate modify glucose homeostasis via parasympathetic activation in zebrafish	177
The impact of the gut microbiota on the reproductive and metabolic endocrine system	166
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder	165
The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice	164
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease	159
Oscillospira - a candidate for the next-generation probiotics	156
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease	147
Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health	142
Specific gut microbiome signature predicts the early-stage lung cancer	133
Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elde	128
Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity	119
Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity	118
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis	115
Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria	115
Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development	114
Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice	113
Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain	113
B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling	106
From correlation to causality: the case of Subdoligranulum	105

Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial	101
Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis	100
The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis	98
The role of gastric microbiota in gastric cancer	97
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases	97
Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics	94
Epigenetic regulation by gut microbiota	92
Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3	91
Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization	89
Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer	86
Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice	82
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans	82
The interplay between Helicobacter pylori and gastrointestinal microbiota	82
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis	81
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	80
Iron homeostasis in host and gut bacteria – a complex interrelationship	80
The effects of dairy and dairy derivatives on the gut microbiota: a systematic literature review	80
Integrated gut virome and bacteriome dynamics in COVID-19 patients	78
Microbiota-derived metabolites as drivers of gut–brain communication	76
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota	74
Bacteroides-dominant gut microbiome of late infancy is associated with enhanced neurodevelopment	74
Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically	73
Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis	72
Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation	72
Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus	71
Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance	71
The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota	71
Gut microbiota derived metabolites contribute to intestinal barrier maturation at the suckling-to-weaning transition	70
Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner	70
Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics	69
Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid	68
The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice	68
Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes	66
Exposure to air pollutants and the gut microbiota: a potential link between exposure, obesity, and type 2 diabetes	66
The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial	63
Therapeutic manipulation of gut microbiota by polysaccharides of Wolfiporia cocos reveals the contribution of the gut fungi-induced PGE2 to alcoholic hepatic steatosis	63
Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis	62
Host–microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling	61
Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease	61
Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients	59
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family	58
Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health	58
Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls	58
Dietary vitamin K is remodeled by gut microbiota and influences community composition	58
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay	58
The intestinal microbiota and metabolites in patients with anorexia nervosa	57
Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus	57
Gut microbiota regulate tumor metastasis via circRNA/miRNA networks	56
Gut microbiota profiles of autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic literature review.	55
Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B	55

Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome– a pilot study	54
Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression	54
Resistant starch, microbiome, and precision modulation	54
Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat	54
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19	53
Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway	53
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome	50
Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis	50
Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response	49
Emerging issues in probiotic safety: 2023 perspectives	49
Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats	48
The composition and richness of the gut microbiota differentiate the top Polish endurance athletes from sedentary controls	48
Klebsiella pneumoniae carriage in low-income countries: antimicrobial resistance, genomic diversity and risk factors	47
Harnessing machine learning for development of microbiome therapeutics	47
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort	46
Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters	46
A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema	46
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR	45
Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?	44
Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader	44
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	44
Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection	43
Human resident gut microbe Bacteroides thetaiotaomicron regulates colonic neuronal innervation and neurogenic function	43
Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation	43
Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health	42
Antimicrobial resistance in enteric bacteria: current state and next-generation solutions	41
Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection	41
Microbiome distinctions between the CRC carcinogenic pathways	41
Enterotoxigenic Escherichia coli : intestinal pathogenesis mechanisms and colonization resistance by gut microbiota	41
Links between gut microbiome composition and fatty liver disease in a large population sample	41
Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence	41
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2	40
The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis	40
The early life education of the immune system: Moms, microbes and (missed) opportunities	40
Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease	40
Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model	40
Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota	40
The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin	40
Bacteroidota and Lachnospiraceae integration into the gut microbiome at key time points in early life are linked to infant neurodevelopment	40
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis	39
The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet	39
Conserved anti-inflammatory effects and sensing of butyrate in zebrafish	39
TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn’s disease	39
Spatial analysis of gut microbiome reveals a distinct ecological niche associated with the mucus layer	39
The gut microbiome stability is altered by probiotic ingestion and improved by the continuous supplementation of galactooligosaccharide	38
Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples	38
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	37
Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Citrobacter rodentium	37
Stratification of athletes’ gut microbiota: the multifaceted hubs associated with dietary factors, physical characteristics and performance	37
Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols	37
Life-long dynamics of the swine gut microbiome and their implications in probiotics development and food safety	37
Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges	37
Dysbiotic microbiota interactions in Crohn’s disease	36
Gut microbes participate in food preference alterations during obesity	36
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening	36
Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: a cross-sectional study of risk factors and bacterial genomic diversity	36
The gut virome in Irritable Bowel Syndrome differs from that of controls	36
The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids	35
Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity	35
The Sporobiota of the Human Gut	35
The role of key gut microbial metabolites in the development and treatment of cancer	35
Maternal consumption of artificially sweetened beverages during pregnancy is associated with infant gut microbiota and metabolic modifications and increased infant body mass index	35
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	35
Dietary cellulose induces anti-inflammatory immunity and transcriptional programs via maturation of the intestinal microbiota	34
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice	34
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management	34
A systematic review of the factors influencing microbial colonization of the preterm infant gut	34
Completion of the gut microbial epi-bile acid pathway	34
Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity	34
Bile acids as modulators of gut microbiota composition and function	34
A bovine lactoferricin-lactoferrampin-encoding Lactobacillus reuteri CO21 regulates the intestinal mucosal immunity and enhances the protection of piglets against enterotoxigenic Escherichia	33
Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolite	33
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies	33
Ethnic diversity in infant gut microbiota is apparent before the introduction of complementary diets	32
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor	32
Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils	32
Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium	31
Long-term effects of antimicrobial drugs on the composition of the human gut microbiota	31
Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome	31
Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury	31

Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota	31
Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California	31
Effects of anti-aging interventions on intestinal microbiota	31
Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease	31
Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis	31
Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206 + macrophages IL-10 activation	30
Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes	30
Human gut microbiome aging clocks based on taxonomic and functional signatures through multi-view learning	30
Gut microbiota: impacts on gastrointestinal cancer immunotherapy	30
Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study	30
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an exp	30
Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis	30
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis	30
Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D	30
Glycated milk protein fermented with Lactobacillus rhamnosus ameliorates the cognitive health of mice under mild-stress condition	29
Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects	29
Impact of quorum sensing signaling molecules in gram-negative bacteria on host cells: current understanding and future perspectives	29
Bifidobacterium animalis: the missing link for the cancer-preventive effect of Gynostemma pentaphyllum	29
Hybrid, ultra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance species in the human gut microbiome	29
Obesity is associated with a distinct brain-gut microbiome signature that connects Prevotella and Bacteroides to the brain’s reward center	29
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach	28
Cellulolytic bacteria in the large intestine of mammals	28
The effect of early probiotic exposure on the preterm infant gut microbiome development	28
Microbial adaptation to the healthy and inflamed gut environments	28
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?	28
Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice	28
Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk	28
Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome	28
Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier	28
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer	28
The interplay between gut bacteria and the yeast Candida albicans	27
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study	27
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice	27
Intestinal phages interact with bacteria and are involved in human diseases	27
The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis	27
Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production	27
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection	26
Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile	26
The clinical evidence for postbiotics as microbial therapeutics	26
The Interface of Vibrio cholerae and the Gut Microbiome	26
Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries	26
Influence of probiotic supplementation on the developing microbiota in human preterm neonates	26
Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota	26
Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect	25
The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites	25
Changes in dietary fiber intake in mice reveal associations between colonic mucin O-glycosylation and specific gut bacteria	25
Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota	25
Human milk microbiota development during lactation and its relation to maternal geographic location and gestational hypertensive status	25
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome	25
Vaccines against gastroenteritis, current progress and challenges	25
The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation	25
Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome	25
Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome	25
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection	25
The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA	25
Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease	25
Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts	25
The evolution and competitive strategies of Akkermansia muciniphila in gut	25
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	25
Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens	24
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	24
Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome	24
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases	24
Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis	24
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process	24
Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection	24
Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection	24
Gene variations in Autism Spectrum Disorder are associated with alternation of gut microbiota, metabolites and cytokines	24
Mucins, gut microbiota, and postbiotics role in colorectal cancer	24
Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment	24
Autophagy mediates ER stress and inflammation in Helicobacter pylori -related gastric cancer	23
Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Fusobacterium spp. on community butyrate production	23
Exosomes transfer miRNAs from cell-to-cell to inhibit autophagy during infection with Crohn’s disease-associated adherent-invasive E. coli	23
Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis	23
Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?	23
Mucus, commensals, and the immune system	23
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	23
High-sugar, high-fat, and high-protein diets promote antibiotic resistance gene spreading in the mouse intestinal microbiota	23
Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection	23
Hyaluronan-induced alterations of the gut microbiome protects mice against Citrobacter rodentium infection and intestinal inflammation	23
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	23
Enriched metabolites that potentially promote age-associated diseases in subjects with an elderly-type gut microbiota	23
Intestinal accumulation of microbiota-produced succinate caused by loss of microRNAs leads to diarrhea in weanling piglets	23
Metabolic impact of persistent organic pollutants on gut microbiota	22
Cohousing-mediated microbiota transfer from milk bioactive components-dosed mice ameliorate colitis by remodeling colonic mucus barrier and lamina propria macrophages	22
Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease	22
Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects	22
Circulating microbiome in patients with portal hypertension	22
Metagenomics reveals impact of geography and acute diarrheal disease on the Central Indian human gut microbiome	22
Luminal microbiota related to Crohn’s disease recurrence after surgery	22
Development of the gut microbiota in healthy children in the first ten years of life: associations with internalizing and externalizing behavior	21
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	21
Functional effects of human milk oligosaccharides (HMOs)	21
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	21
Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment	21